on 23 Jun 2020
Last Applicant/ Owned by
1334 Parkview Ave, Suite 230
Manhattan Beach
CA
90266
Serial Number
88225543 filed on 11th Dec 2018
Registration Number
6086517 registered on 23rd Jun 2020
Correspondent Address
Aaron D. Hendelman
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"BY REGENERATIVE SCIENCE"
"BY REGENERATIVE SCIENCE" Color is not claimed as a feature of the mark. biologics preparations, namely, ophthalmic; biologics preparations for the treatment of ophthalmic diseases and conditions; biologics preparations for the treatment of dry eyes with eye drops The mark consists of the phrase "GENESIS 2.0" above the words "by REGENERATIVE SCIENCE". The word "by" begins beneath the first "E" Read More
biologics preparations, namely, ophthalmic; biologics preparations for the treatment of ophthalmic diseases and conditions; biologics preparations for the treatment of dry eyes with eye drops
30th Apr 2019
30th Apr 2019
No 88225543
No Service/Collective Mark
No 56390-TM1020
No
No
No
No
No
No
No
No
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
The mark consists of the phrase "GENESIS 2.0" above the words "by REGENERATIVE SCIENCE". The word "by" begins beneath the first "E" of "GENESIS". Beginning above the first "E" of "GENESIS" is an arc comprised of seven separate circles. The circles increase in size as they arc towards the left. The final and largest of the seven separate circles of the arc ends to the left and below the "G" in "GENESIS".
Status Date | Action Taken |
---|---|
23rd Jun 2020 | REGISTERED-PRINCIPAL REGISTER |
19th May 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
16th May 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
12th May 2020 | STATEMENT OF USE PROCESSING COMPLETE |
12th May 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
28th Apr 2020 | USE AMENDMENT FILED |
28th Apr 2020 | TEAS STATEMENT OF USE RECEIVED |
16th Apr 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
14th Apr 2020 | EXTENSION 1 FILED |
14th Apr 2020 | EXTENSION 1 GRANTED |